Much has been said about potential over-diagnosis and over-treatment as a result of screening programmes and fast-improving diagnostic tools, writes European Alliance for Personalised Medicine (EAPM)...
The issue of the European Commission’s proposals on more EU-wide cooperation in health technology assessment, or HTA, has been discussed in the European Parliament on several...
The European Alliance for Personalised Medicine (EAPM) is to host a meeting on the ongoing issue of HTA in the Brussels European Parliament on 26 September...
It’s all about the teamwork… We hear that again and again when bosses praise their staff, when football managers are happy after a good result, when...
Greetings from EAPM! For many of you, it’s welcome back to work after the summer holidays (which we all hope were enjoyable), while some of the...
The expanding and very swiftly moving world of genomics in health care has opened up many new opportunities, but evaluations have to be done on the...
The European Commission’s plans on supplementary protection certificates (SPCs) waivers are ongoing, and EAPM’s members and associates need to be aware of the direction in which...